Retatrutide | |
Retatrutide is a novel multi-receptor agonist targeting GLP-1, GIP, and glucagon receptors, studied for the treatment of obesity and metabolic disorders. It promotes weight loss by enhancing energy expenditure, reducing appetite, and improving insulin sensitivity. Early clinical trials have shown promising results, with significant reductions in mass and improvements in glycemic control, positioning Retatrutide as a potential breakthrough studied peptide. ![]() | |
Target Nation: All Nations Target City : All Cities Last Update : 20 June 2025 7:57 AM Number of Views: 40 | Item Owner : jennie Contact Email: Contact Phone: +85265295284 |
Friendly reminder: Click here to read some tips. |